Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

NCT06668389 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease
Repaired Tetralogy of Fallot (rTOF)
Pulmonary Regurgitation
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor
Dapagliflozin (Forxiga)

Interventions

DRUG: SGLT2 inhibitor (Dapagliflozin 10mg)

Sponsor

The University of Hong Kong